Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys

Acta Tropica

Volumn 86, Issue 1, 2003, Pages 35-40

  Puri, S K ^a   Dutta, G P ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Malaria; Plasmodium cynomolgi; Plasmodium fragile; Primaquine; Rhesus monkey; Tafenoquine; WR 238605

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; PRIMAQUINE; TAFENOQUINE;

DISEASE CONTROL; MALARIA; PRIMATE;

ANIMAL MODEL; ARTICLE; FEMALE; MALARIA; MALE; NONHUMAN; PARASITEMIA; PLASMODIUM CYNOMOLGI; PLASMODIUM FRAGILE; RHESUS MONKEY; SCHIZONT; TROPHOZOITE;

MACACA MULATTA; PLASMODIUM CYNOMOLGI; PLASMODIUM FRAGILE; PLASMODIUM VIVAX; SIMIAE;

EID: 0037395943     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(02)00289-9     Document Type: Article

References (16)

1. Baird J.K., Fryauff D.J., Basri H., Bangs M.J., Subianto B., Wiady I., Purnomo, Leksana B., Masbar S., Richie T.L., Jones T.R., Tjitra E., Wignall F.S., Hoffman S.L. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene. 52:1995;479-484.
2. Brueckner R.P., Coster T., Wesche D.L., Shmuklarshby M., Schuster B.G. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Antimicrobial Agents and Chemotherapy. 42:1998;1293-1294.
3. Brueckner R.P., Lasseter K.C., Lin E.T., Schuster B.G. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. American Journal of Tropical Medicine and Hygiene. 58:1998;645-649.
4. Coatney G.R., Collins W.E., Warren M., Contacos P.G. Primate Malarias. 1971;Department of Health Education and Welfare, US Govt. Publication.
5. Cooper R.D., Milhous W.K., Rieckmann K.H. The efficacy of WR 238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax. Transactions Royal Society Tropical Medicine and Hygiene. 88:1994;691-692.
6. Fryauff D., Baird H., Sumawinata I., Purnomo, Richie T., Ohrt C., Mouzin E., Church C., Richards A., Subianto B., Wignall F., Hoffman S.L. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet. 346:1995;1190-1193.
7. Lell B., Faucher J., Missinou M.A., Borrmann S., Danglemaier O., Horton J., Kremsner P.G. Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet. 355:2000;2041-2045.
8. Murphy G.S., Basri H.P., Anderson E.M., Bangs M.J., Mount D.L., Ya-Ping S., Lal A.A., Wiady I., Gorden J., Purwickusume A.R., Harjosuwarno S., Sorensen K., Hoffman S.L. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 341:1993;96-100.
9. Obaldia N., Rossan R.N., Cooper R.D., Kyle D.E., Nuzum E.O., Rieckmann K.H., Shanks G.D. WR 238605, chloroquine and their combinations as blood schizontocides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. American Journal of Tropical Medicine and Hygiene. 56:1997;508-510.
10. Olliaro P., Cattani J., Wirth D. Malaria, the submerged disease. Journal of American Medical Association. 275:1996;230-233.
11. Peters W., Robinson B.L., Milhous W.K. The chemotherapy of rodent malaria LI. Studies on a new 8-aminoquinoline, WR 238605. Annals of Tropical Medicine and Parasitology. 87:1993;547-552.
12. Pukrittayakamee S., Vanijanonta S., Chantra A., Clemens R., White N.J. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. Journal of Infectious Diseases. 169:1994;932-935.
13. Rieckmann K.H., Davis D.R., Hutton D.C. Plasmodium vivax resistance to chloroquine. Lancet. 2:1989;1183-1184.
14. Than M., Kyaw M.P., Soe A.Y., Gyi K.K., Sbai M., Oo M. Development of resistance to chloroquine by P. vivax in Myanmar. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89:1995;307-308.
15. Weiss W.R., Oloo A.J., Johnson A., Koech D., Hoffman S.L. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya; comprison with mefloquine, doxycycline, and chloroquine plus proguanil. Journal of Infectious Diseases. 171:1995;1569-1575.
16. WHO, 1990. Practical chemotherapy of malaria. World Health Organization Technical Report Series No. 805, pp. 128.